Aquestive Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$5.41(as of Sep 5, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Aquestive Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$5.41
Ticker SymbolAQST
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees142
CountyUSA
Market Cap$477.8M
EBIDTA-52.0M
10-Day Moving Average3.99
P/E Ratio-7.73
20-Day Moving Average3.98
Forward P/E Ratio0.00
50-Day Moving Average3.92
Earnings per Share-0.69
200-Day Moving Average3.37
Profit Margin-135.44%
RSI76.52
Shares Outstanding121.0M
ATR0.28
52-Week High5.80
Volume13,596,783
52-Week Low2.12
Most Recent Support Level3.73
Book Value-72.6M
Most Recent Resistance Level4.00
P/B Ratio-6.92
Upper Keltner4.61
P/S Ratio11.39
Lower Keltner3.34
Debt-to-Equity Ratio4.61
Next Earnings Date11/10/2025
Cash Surplus37.4M
Next Ex-Dividend DateUnknown

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; KYNMOBI a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary pipeline products include Anaphylm, an epinephrine sublingual film, which is in phase 3 clinical trial for the emergency treatment of allergic reactions, including anaphylaxis; and AQST-108, a topical gel that is in phase 2 clinical trial for the treatment of alopecia areata. In addition, it develops PharmFilm technology for patients suffering from certain central nervous system disorders; and Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.

Aquestive Therapeutics Inc In Our Stock Scanner

As of Sep 05, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.